Babylon Holdings Ltd
OTC:BBLNF
Babylon Holdings Ltd
Research & Development
Babylon Holdings Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Babylon Holdings Ltd
OTC:BBLNF
|
Research & Development
-$79.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Research & Development
-$750.1m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-29%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Research & Development
-$103.2m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Research & Development
-$93m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Research & Development
-$88.7m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-10%
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
Research & Development
-$54.6m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Babylon Holdings Ltd
Glance View
Babylon Holdings Ltd. engages in the development of a mobile phone-based healthcare application. The company is headquartered in Austin, Texas and currently employs 1,895 full-time employees. The company went IPO on 2021-03-30. The firm's digital clinical platform makes information available to members so that they can monitor their health information on mobile devices, delivering digital care in countries as varied as the United States and Rwanda. The company provides 24/7 digital access to medical professionals in the United States and the United Kingdom. Its platform delivers standardized treatment protocols, administrative practices, technology, and automation, such as care for acute and chronic conditions, including chronic pain, pregnancy, cardiovascular disease, diabetes, and numerous other health concerns in a longitudinal manner. Its flagship holistic solution, Babylon 360, combines its cutting-edge technologies with human clinical expertise and provides managed care for its members across the care continuum.
See Also
What is Babylon Holdings Ltd's Research & Development?
Research & Development
-79.2m
USD
Based on the financial report for Dec 31, 2022, Babylon Holdings Ltd's Research & Development amounts to -79.2m USD.
What is Babylon Holdings Ltd's Research & Development growth rate?
Research & Development CAGR 1Y
-16%
Over the last year, the Research & Development growth was -16%.